Cytomegalovirus

Worldwide Vaccine Program Could Eliminate CMV

Published in TB and Outbreaks Week, March 27th, 2001

by N.R. Saltmarsh, staff medical writer - Cytomegalovirus (CMV) is an ideal candidate for worldwide eradication through immunization, say researchers working in England.

"Using seroprevalence data from two large antenatal populations (in excess of 14,000 women) coupled with a mathematical modeling approach, we have shown that CMV has a low force of infection (ca. 0.03 per seronegative per annum) and its basic reproductive number R-0 is relatively modest at 2.4," reported P.D. Griffiths and colleagues.

Nevertheless, CMV is the leading cause of mental retardation in children, they noted.

The researchers calculated that the critical...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of TB and Outbreaks Week

Source: TB and Outbreaks Week (2001-03-27)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry